Matthew Holt, also known as Matt, serves as a Managing Director at New Mountain Capital, LLC. Mr. Holt joined New Mountain in 2001 and focuses on growth buyouts across a range of industries including healthcare products, health technology, materials and infrastructure. He previously worked in the Mergers and Acquisitions Group at Lehman Brothers from 1999 to 2001. He serves as the Lead Director or Chairman of Avantor, Inc., CIOX Health, Censeo+Advance, Convey Health Solutions, Inc., Cytel, Equian LLC, Revint Solutions and Zep, Inc. He also serves as a Director of Topix Pharmaceuticals, Gelest, and TRC Companies. Mr. Holt has previously served as Lead Director of Bellerophon Therapeutics, Inc., Ikaria, Inc., Nusil Technology LLC, and Director of MailSouth.
Mr. Holt holds an A.B. with honors in English and American Literature and Language from Harvard College in 1999.